Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver microcirculation refers to the complex capillary system within the liver, consisting of the hepatic artery, portal vein, hepatic sinusoids, central vein, and associated cellular elements such as hepatic stellate cells, sinusoidal endothelial cells, Kupffer cells, and pit cells[1][3][5][6]. The system is responsible for the liver’s unique dual blood supply, with blood from both the portal vein and hepatic artery converging in the sinusoids before draining into the central vein. This arrangement ensures the efficient delivery of oxygen and nutrients, removal of metabolic waste and toxins, and participation in immune surveillance[1][3][5][6]. Functionally, the liver’s microcirculation is crucial for metabolic regulation, detoxification, blood volume, and immune responses. Disruption of this system—due to stress, drugs, alcohol, or viral infection—can lead to conditions such as acute liver failure, fatty liver disease, cirrhosis, portal hypertension, and liver cancer[1][3][4][7]. While some cells and pathways within the hepatic microcirculation are drug targets (e.g., hepatic stellate cells, endothelin signaling), “liver microcirculation” itself does not represent a single druggable entity or molecular target. Key supporting details: - This term aggregates anatomical (vascular/cellular) features, not a protein, gene, or receptor[1][3][5][6]. - It is a pathophysiological system central to many liver diseases, but not a singular druggable entity[1][3][4][7]. - Individual components—stellate cells, endothelial receptors/channels—are sometimes drug targets, but “liver microcirculation” is not equivalent to these[2][6][7]. - Various imaging, pharmacological, and interventional approaches seek to modulate liver microcirculation, but these act upon its components rather than the overarching system[5][4][1]. In summary, "liver microcirculation" is a complex physiological system essential for liver function and implicated in multiple disease states, but not a molecule, receptor, or single drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver microcirculation.